NASDAQ · BENFW

Beneficient

$0.01 -$0.00 (-5.51%) 1D Market open

Key Metrics

Market cap
P/E · TTM
−$39.13M
Revenue · TTM
−$87.43M
Net income
EPS · TTM
Dividend yield
Free cash flow −$38.81M
Beta · 1Y -0.30
EBITDA · TTM −$163.77M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 19
    The stock moved +29.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 19
  • Apr 30
    From its Mar 31 high, the share price fell 31%.

    Peak close $0.01 on Mar 31; trough close $0.01 on Apr 30. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -31%
  • Mar 31
    The stock moved +35.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 31

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap
Enterprise value
Shares outstanding
52-wk range$0.00 – $0.04
Avg volume · 20D229.2K
Net cash
Book value / share
IndustryFinance Services
ExchangeNASDAQ
About Beneficient
IPO dateJun 8, 2023
Employees55

Beneficient is a technology-enabled financial services holding company providing liquidity solutions and trust products and services to participants in the alternative assets industry through an online platform, AltAccess.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating 420.5%
Net 223.5%
FCF 99.2%
ROE / ROIC 78.0% · 85.9%

Financial Health

Current ratio
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital

Cash Flow · TTM

Operating CF −$38.72M
Capex −$96.00K
Free cash flow −$38.81M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings